Thiadiazine derivatives and use thereof as positive AMPA receptor modulators
Compounds of formula (I): wherein: A represents thienyl, furyl, pyrrolyl, oxathiol, thiazole, isothiazole, oxazole or imidazole, represents a single bond or a double bond, R 1 represents hydrogen, linear or branched (C 1 -C 6 )alkyl optionally substituted by one or more groups selected from halogen or (C 1 -C 6 )alkoxy-(C 1 -C 6 )alkyl, R 2 represents hydrogen or linear or branched (C 1 -C 6 )alkyl group optionally substituted by one or more halogen, R 3 represents hydrogen or a group selected from linear or branched (C 1 -C 6 )alkyl, CONHR′ and SO 2 NHR′ wherein R′ represents linear or branched (C 1 -C 6 )alkyl, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same, which are useful as AMPA inhibitors.
1. A compound selected from those of formula (I):
wherein:
A represents a thienyl, furyl or pyrrolyl group selected from the groups A 1 , A 2 , and A 3 :
wherein X represents sulphur, oxygen or nitrogen and R a and R b , which may be identical or different, each independently of the other represents hydrogen, linear or branched (C 1 -C 6 )alkyl (optionally substituted by one or more fluorine), linear or branched (C 1 -C 6 )alkoxy, halogen, hydroxy, amino (optionally substituted by linear or branched (C 1 -C 6 )alkylcarbonyl or by one or two linear or branched (C 1 -C 6 )alkyl), carboxyl or linear or branched (C 1 -C 6 )alkoxycarbonyl,
an oxathiol group selected from the groups A 4 , A 5 , A 6 , and A 7 :
wherein R a is as defined hereinbefore,
a thiazole group selected from the groups A 8 and A 9 :
wherein R a is as defined hereinbefore,
an isothiazole group selected from the groups A 10 and A 11 :
wherein R a is as defined hereinbefore,
an oxazole group selected from the groups A 12 , A 13 , A 14 , and A 15 :
wherein R a is as defined hereinbefore,
or an imidazole group of formula A 16 :
wherein R a is as defined hereinbefore,
represents a single bond or a double bond,
R 1 represents hydrogen, linear or branched (C 1 -C 6 )alkyl optionally substituted by one or more fluorine atoms, one or more halogen atoms other than fluorine, or (C 1 -C 6 )alkoxy-(C 1 -C 6 )alkyl in which each alkyl moiety may be linear or branched,
R 2 represents hydrogen or linear or branched (C 1 -C 6 )alkyl optionally substituted by one or more fluorine atoms, or a plurality of halogen atoms other than fluorine,
R 3 represents hydrogen or a group selected from linear or branched (C 1 -C 6 )alkyl, CONHR′ and SO 2 NHR′ wherein R′ represents linear or branched (C 1 -C 6 )alkyl,
its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
2. A compound of claim 1 , wherein A represents a thienyl group selected from the groups A 1 , A 2 and A 3 wherein X represents sulphur, its enantiomers and diastereoisomers, and also addition salts thereof with a pharmaceutically acceptable acid or base.
3. A compound of claim 1 , wherein A represents a thienyl group selected from the groups A 1 and A 2 wherein X represents sulphur, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
4. A compound of claim 2 , wherein R a and R b each independently of the other represents hydrogen or chlorine, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
5. A compound of claim 1 , wherein R 1 represents hydrogen or linear or branched (C 1 -C 6 )alkyl, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
6. A compound of claim 5 , wherein R 1 represents methyl, ethyl or isopropyl, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
7. A compound of claim 1 , wherein R 2 represents hydrogen, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
8. A compound of claim 1 , wherein R 3 represents hydrogen or CONHR′, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
9. A compound of claim 1 which is selected from:
6-chloro-4-ethyl-3,4-dihydro-2H-thieno[3,2-e][1,2,4]thiadiazine 1,1-dioxide,
6-chloro-4-isopropyl-3,4-dihydro-2H-thieno[3,2-e][1,2,4]thiadiazine 1,1-dioxide, and
5,7-dichloro-4-methyl-3,4-dihydro-2H-thieno[3,4-e][1,2,4]thiadiazine 1,1-dioxide.
10. A pharmaceutical composition comprising as active ingredient a compound of claim 1 , in combination with one or more inert, non-toxic, pharmaceutically acceptable carriers.
11. A method of treating a living animal body, including a human, afflicted with a condition selected from anxiety and depression, comprising the step of administering to the living animal body, including a human, an amount of a compound of claim 1 which is effective for alleviation of the condition.